Inna Tchoukina1, Keyur B Shah2, Jennifer T Thibodeau3, Jerry D Estep4, Anuradha Lala5, David E Lanfear6, Nisha A Gilotra7, Salpy V Pamboukian8, Douglas A Horstmanshof9, Dennis M Mcnamara10, Donald C Haas11, Ulrich P Jorde12, Rhondalyn C Mclean13, Thomas M Cascino14, Shokoufeh Khalatbari14, Blair Richards14, Matheos Yosef14, Cathie Spino14, J Timothy Baldwin15, Douglas L Mann16, Keith D Aaronson14, Garrick C Stewart17. 1. Virginia Commonwealth University, Richmond, Virginia. Electronic address: inna.tchoukina@vcuhealth.org. 2. Virginia Commonwealth University, Richmond, Virginia. 3. University of Texas Southwestern Medical Center, Dallas, Texas. 4. Cleveland Clinic, Cleveland, Ohio. 5. Mount Sinai Icahn School of Medicine, New York, New York. 6. Henry Ford Hospital, Detroit, Michigan. 7. Johns Hopkins University School of Medicine, Baltimore, Maryland. 8. University of Alabama at Birmingham, Birmingham, Alabama. 9. INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma. 10. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 11. Abington-Jefferson Health, Abington, Pennsylvania. 12. Montefiore Medical Center, Bronx, New York. 13. University of Pennsylvania, Philadelphia, Pennsylvania. 14. University of Michigan, Ann Arbor, Michigan. 15. National Heart, Lung, and Blood Institute, Bethesda, Maryland. 16. Washington University, St. Louis, Missouri. 17. Brigham and Women's Hospital, Boston, Massachusetts.
Abstract
BACKGROUND: Worsening heart failure (HF) and health-related quality of life (HRQOL) have been shown to impact the decision to proceed with left ventricular assist device (LVAD) implantation, but little is known about how socioeconomic factors influence expressed patient preference for LVAD. METHODS AND RESULTS: Ambulatory patients with advanced systolic HF (n=353) reviewed written information about LVAD therapy and completed a brief survey to indicate whether they would want an LVAD to treat their current level of HF. Ordinal logistic regression analyses identified clinical and demographic predictors of LVAD preference. Higher New York Heart Association (NYHA) class, worse HRQOL measured by Kansas City Cardiomyopathy Questionnaire, lower education level, and lower income were significant univariable predictors of patients wanting an LVAD. In the multivariable model, higher NYHA class (OR [odds ratio]: 1.43, CI [confidence interval]: 1.08-1.90, P = .013) and lower income level (OR: 2.10, CI: 1.18 - 3.76, P = .012 for <$40,000 vs >$80,000) remained significantly associated with wanting an LVAD. CONCLUSION: Among ambulatory patients with advanced systolic HF, treatment preference for LVAD was influenced by level of income independent of HF severity. Understanding the impact of socioeconomic factors on willingness to consider LVAD therapy may help tailor counseling towards individual needs.
BACKGROUND: Worsening heart failure (HF) and health-related quality of life (HRQOL) have been shown to impact the decision to proceed with left ventricular assist device (LVAD) implantation, but little is known about how socioeconomic factors influence expressed patient preference for LVAD. METHODS AND RESULTS: Ambulatory patients with advanced systolic HF (n=353) reviewed written information about LVAD therapy and completed a brief survey to indicate whether they would want an LVAD to treat their current level of HF. Ordinal logistic regression analyses identified clinical and demographic predictors of LVAD preference. Higher New York Heart Association (NYHA) class, worse HRQOL measured by Kansas City Cardiomyopathy Questionnaire, lower education level, and lower income were significant univariable predictors of patients wanting an LVAD. In the multivariable model, higher NYHA class (OR [odds ratio]: 1.43, CI [confidence interval]: 1.08-1.90, P = .013) and lower income level (OR: 2.10, CI: 1.18 - 3.76, P = .012 for <$40,000 vs >$80,000) remained significantly associated with wanting an LVAD. CONCLUSION: Among ambulatory patients with advanced systolic HF, treatment preference for LVAD was influenced by level of income independent of HF severity. Understanding the impact of socioeconomic factors on willingness to consider LVAD therapy may help tailor counseling towards individual needs.
Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: Soon J Park; Carmelo A Milano; Antone J Tatooles; Joseph G Rogers; Robert M Adamson; D Eric Steidley; Gregory A Ewald; Kartik S Sundareswaran; David J Farrar; Mark S Slaughter Journal: Circ Heart Fail Date: 2012-01-26 Impact factor: 8.790
Authors: Courtenay R Bruce; Kristin M Kostick; Estevan D Delgado; Lidija A Wilhelms; Robert J Volk; Martin L Smith; Sheryl A McCurdy; Matthias Loebe; Jerry D Estep; Jennifer S Blumenthal-Barby Journal: J Card Fail Date: 2015-06-22 Impact factor: 5.712
Authors: Kristin M Kostick; Courtenay R Bruce; Charles G Minard; Robert J Volk; Andrew Civitello; Selim R Krim; Douglas Horstmanshof; Vinay Thohan; Matthias Loebe; Mazen Hanna; Brian A Bruckner; J S Blumenthal Barby; Jerry D Estep Journal: J Card Fail Date: 2018-09-07 Impact factor: 5.712
Authors: James K Kirklin; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Susan L Myers; Marissa A Miller; J Timothy Baldwin; James B Young; David C Naftel Journal: J Heart Lung Transplant Date: 2017-07-15 Impact factor: 10.247
Authors: Jennifer S Blumenthal-Barby; Kristin M Kostick; Estevan D Delgado; Robert J Volk; Holland M Kaplan; L A Wilhelms; Sheryl A McCurdy; Jerry D Estep; Matthias Loebe; Courtenay R Bruce Journal: J Heart Lung Transplant Date: 2015-03-31 Impact factor: 10.247
Authors: Kevin J Clerkin; Arthur Reshad Garan; Brian Wayda; Raymond C Givens; Melana Yuzefpolskaya; Shunichi Nakagawa; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini; Paolo C Colombo; Veli K Topkara Journal: Circ Heart Fail Date: 2016-10 Impact factor: 8.790
Authors: Molly Magid; Colleen K McIlvennan; Jaqueline Jones; Carolyn T Nowels; Larry A Allen; Jocelyn S Thompson; Dan Matlock Journal: Am Heart J Date: 2016-07-16 Impact factor: 4.749
Authors: Colleen K McIlvennan; Jocelyn S Thompson; Daniel D Matlock; Joseph C Cleveland; Shannon M Dunlay; Shane J LaRue; Eldrin F Lewis; Chetan B Patel; Mary Norine Walsh; Larry A Allen Journal: J Cardiovasc Nurs Date: 2016 Nov/Dec Impact factor: 2.083
Authors: Thomas M Cascino; Sriram Somanchi; Monica Colvin; Grace S Chung; Alexander A Brescia; Michael Pienta; Michael P Thompson; James W Stewart; Devraj Sukul; Daphne C Watkins; Francis D Pagani; Donald S Likosky; Keith D Aaronson; Jeffrey S McCullough Journal: JAMA Netw Open Date: 2022-07-01